1) Dupuy AM, Lehmann S, Cristol JP:Protein biochip systems for the clinical laboratory. Clin Chem Lab Med 43:1291-302,2005
2) Hou C, Herr AE:Clinically relevant advantages in on-chip affinity-based electrophoresis and electrochromatography. Electrophoresis 29:3306-3319,2008
3) Kawabata T, Wada HG, Watanabe M, et al:"Electrokinetic Analyte Transport Assay" for alpha-Fetoprotein immunoassay integrates mixing, reaction and separation on-chip. Electrophoresis 29:1399-1406,2008
4) Kagebayashi C, Yamaguchi I, Akinaga A, et al:An Automated Immunoassay System for Determination of AFP-L3% using On-chip Electrokinetic reaction and Separation by Affinity Electrophoresis. Analytical Biochemistry 388:306-311,2009
5) Taketa K, Endo Y, Sekiya C, et al:A Collaborative Study for the Evaluation of Lectin-Reactive α-Fetoproteins in Early Detection of Hepatocellular Carcinoma. Cancer Res 53:5419-5423,1993
6) Noda K, Miyoshi E, Uozumi N, et al:Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues:a possible implication for increased fucosylation of alpha-fetoprotein. Hepatology 28:944-952,1998
7) Noda K, Miyoshi E, Gu J, et al:Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res 63:6282-6289,2003
8) 多田俊史,熊田卓,豊田秀徳,他:肝細胞癌における高感度化血清AFP-L3%測定の診断マーカーとしての臨床的有用性.肝臓 50(supl):A127,2009
9) 山本健太,熊田卓,豊田秀徳,他:高感度化血清AFP-L3%測定による肝細胞癌の予後マーカーとしての臨床的有用性,肝臓 50(supl):A89,2009